Health Policy

Our work focuses on a rigorous evaluation of health policies and their association with cardiovascular health and outcomes

Financial Toxicity from Cardiovascular Care

We have uncovered a large burden of financial toxicity from healthcare among patients with cardiovascular disease, a function of both their emergency and acute care needs as well as out-of-pocket expenses on health insurance and health maintenance

Circ CRN.jpg

Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017

Circulation. 2019;140:2067–2075

FT JAHA.png

Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions

J Am Heart Assoc. 2020 Oct 20;9(19):e017793

JAMA Cardiology OOP 4.png

Association of Out-of-Pocket Annual Health Expenditures With Financial Hardship in Low-Income Adults With Atherosclerotic Cardiovascular Disease in the United States

JAMA Cardiol. 2018;3(8):729-738

Circ+CHE.jpg

Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke Among Uninsured in the United States

Circulation. 2018;137:408–410

Hospital Readmissions

In a series of investigations, we rigorously evaluated the effects of the Hospital Readmission Reduction Program on readmissions, mortality, and post-acute care

BMJ readmission.jpg

Post-discharge acute care and outcomes following readmission reduction initiatives: national retrospective cohort study of Medicare beneficiaries in the United States

BMJ 2020;368:l6831

Khera JACC.jpg

Evaluation of 30-Day Hospital Readmission and Mortality Rates Using Regression-Discontinuity Framework

J Am Coll Cardiol. 2019 Jul, 74 (2) 219–234

khera JNO.png

Association of the Hospital Readmissions Reduction Program With Mortality During and After Hospitalization for Acute Myocardial Infarction, Heart Failure, and Pneumonia

JAMA Netw Open. 2018;1(5):e182777